Clinical Trials on Amyloid in France

Total 590 results

Ramsay Générale de Santé
European Clinical Trial Experts Network

Recruiting

Detection of Amyloid Deposits in the Wrist by MRI With Mapping and High Resolution Sequences in Systemic Amyloidosis (AMYLOCARP) (AMYLOCARP)

Amyloid | Systemic Amyloidosis

France
Assistance Publique Hopitaux De Marseille

Completed

Expanding the Biomarkers in Familial Amyloid Neuropathy: MRI and Motor Unit Estimation by Electrophysiological Study

Amyloid Neuropathies | Transthyretin Amyloidosis

France
Algalarrondo Vincent
Bichat Hospital; Bioquantis

Recruiting

Artificial Intelligence to Assist the Echocardiographic Identification of Transthyretin Cardiac Amyloidosis (AI-ATTR-ECHO)

Transthyretin Cardiac Amyloidosis | Transthyretin Amyloid Cardiomyopathy | Amyloid Cardiomyopathy

France
University Hospital, Bordeaux
University of Bordeaux

Completed

Early and Systematic Screening in Chronic Neuropathy (TTR-FAP)

Amyloid Neuropathies, Familial

France
Central Hospital, Nancy, France

Recruiting

Assessment of 18F-Florbetaben Whole-body PET for the Detection of Cardiac and Extracardiac Sites of Amyloid Deposits (CAPRI)

Cardiac Amyloidosis

France
Association for Training, Education, and Research...

Completed

Sequential Conditioning in Haploidentical Transplantation for Refractory Acute Myeloid Leukemia (SET-HAPLO)

Refractory Acute Myeloid Leukemia

France
Centre Leon Berard
NETRIS Pharma

Recruiting

Acute Myeloid Leukemia Treated With With NETrin Abs in Combination With [AZACITIDINE + VENETOCLAX] (AML-NET)

Acute Myeloid Leukemia Refractory

France
Intellia Therapeutics

Active, not recruiting

Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NTLA-2001 in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy (ATTRv-PN) and Patients With Transthyretin Amyloidosis-Related Cardiomyopathy (ATTR-CM)

Transthyretin-Related (ATTR) Familial Amyloid Cardiomyopathy | Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy | Wild-Type Transthyretin Cardiac Amyloidosis

France, United Kingdom, New Zealand, Sweden
Assistance Publique Hopitaux De Marseille

Unknown

Interest of a Therapeutic Follow-up of the Cytarabine in the Acute Myeloid Leukaemia: Is There Constitutional Biomarkers

Acute Myeloid Leukemia

France
Institut Paoli-Calmettes
Cancer Research Center of Marseille

Unknown

ChEmo-Genomics Based Treatment of Acute Myeloid Leukemia (CeGAL)

Leukemia, Myeloid, Acute

France
French Innovative Leukemia Organisation
Celgene Corporation

Completed

Elderly Patients With Acute Myeloid Leukemia (AML), Maintenance Phase After Complete Remission (CR)

Acute Myeloid Leukemia

France
French Innovative Leukemia Organisation
Genzyme, a Sanofi Company; Acute Leukemia French Association

Terminated

Study in Plerixafor and Granulocyte-colony Stimulating Factor Patients With Relapse Acute Myeloid Leukemia (PRIMAL)

Acute Myeloid Leukemia

France
Assistance Publique - Hôpitaux de Paris
French Innovative Leukemia Organisation; Acute Leukemia French Association

Completed

Timed-Sequential Induction in CBF-AML

Acute Myeloid Leukemia

France
Nantes University Hospital

Completed

Prospective Randomized Study Comparing One or Two High Dose Chemotherapy Regimen Followed by Autologous Stem Cell Transplantation (AML2001)

Acute Myeloid Leukemia

France
Assistance Publique - Hôpitaux de Paris
Chiron Corporation

Unknown

Treating Patients With Childhood Acute Myeloid Leukemia With Interleukin-2 (Elam02)

Leukemia

France
French Innovative Leukemia Organisation

Completed

Lomustine and Intermediate Dose Cytarabine in Older Patients With AML

Acute Myeloid Leukemia

France
Assistance Publique - Hôpitaux de Paris
Institut National de la Santé Et de la Recherche Médicale, France; Gustave... and other collaborators

Active, not recruiting

MIF Involvement in AML (MIFAML)

Acute Myeloid Leukemia

France
University Hospital, Bordeaux

Completed

Immune Checkpoint Receptors in AML-Leukemic Initiating Cells (ICAML-LIC)

Acute Myeloid Leukemia

France
University Hospital, Toulouse

Completed

Study of Dendrogenin A / Oxysterols Balance Between Healthy Volunteers and Acute Myeloid Leukemia Patients (OXYLAM)

Acute Myeloid Leukemia

France
French Innovative Leukemia Organisation
Novartis; Schering SA

Completed

GOELAMS SA4 Study: the Role of Fludarabine in the Treatment of Acute Myeloid Leukemia in the Elderly

Acute Myeloid Leukemia

France
Assistance Publique - Hôpitaux de Paris

Completed

Haploidentical NK-cell Infusion in Acute Myeloid Leukemia (NK)

Acute Myeloid Leukemia

France
French Innovative Leukemia Organisation
Fresenius Kabi

Completed

Pilot Study Efficacy and Tolerance Fish Oil Emulsion Daunorubicin and Cytarabine Treatment of AML Younger Patients (FAMYLY)

Acute Myeloid Leukemia (AML)

France
Hospices Civils de Lyon

Completed

Transfusion Dependency at Diagnosis and Transfusion Intensity During Initial Chemotherapy Are Associated With Poorer Outcomes in Adult Acute Myeloid Leukaemia

Acute Myeloid Leukaemia

France
Hospices Civils de Lyon

Recruiting

Pharmacokinetics Variability of Posaconazole (PCZ) and Its Glucuronide Metabolite During Induction and Consolidation Treatments in Patients With Acute Myeloid Leukemia (AML): a Covariate Analysis With the Tablets Formulation and Evaluation of the Potential Risk of Hepatotoxicity (Posa-Pk)

Leukemia, Myeloid, Acute

France
Institut Paoli-Calmettes

Completed

Pilot Study Immunomonitoring Natural Killers Cells in Patients With Myeloid Malignancies Treated With Lenalidomide

Acute Myeloid Leukemia or Myelodysplasic Syndrome

France
University Hospital, Caen

Recruiting

Relation Between Venetoclax Plasma Concentration and Remission in Adults With Acute Myeloid Leukemia (PREDICLAX)

Adult Acute Myeloid Leukemia

France
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Study of Management and Prognosis of Patients With Acute Myeloblastic Leukemia in Saint-Antoine Hospital (LAMSA)

Acute Myeloid Leukemia

France
Nantes University Hospital

Completed

Monocentric Phase 1 Study With Escalation of Doses of Tocilizumab in Combination With Chemotherapy (Idarubicin and Cytarabine) in Patients With Acute Myeloblastic Leukemia (AML) (Tocilam)

Acute Myeloid Leukemia (AML)

France
Hospices Civils de Lyon

Completed

Study of Intracellular Nucleotide Pools Determination as Biomarker of the Efficacy of the Induction Treatment in Acute Myeloid Leukemia (NUCLARA)

Acute Myeloid Leukemia

France
Assistance Publique - Hôpitaux de Paris

Completed

Reduction of Cord Blood Transplantation Toxicity in Patients With Acute Myeloid Leukemia (MINICORD)

Acute Myeloid Leukemia

France
Nantes University Hospital

Recruiting

Dose-escalation of Siltuximab in Combination With Idarubicin and Cytarabine Chemotherapy in Patients With Acute Myeloblastic Leukaemia (AML) With Poor Prognosis: SILTUXILAM (SILTUXILAM)

Acute Myeloid Leukemia (AML)

France
Nantes University Hospital

Recruiting

Injection of Lymphocytes From Haplo-identical Donor Following Chemotherapy in Patients With High-risk Acute Myeloblastic Leukemia Not Eligible for an Allogeneic Hematopoietic Stem Cell Transplantation (ILDA)

Acute Myeloid Leukemia (AML)

France
University Hospital, Toulouse

Active, not recruiting

Prognostic Factors and the Impact of Various Management of Acute Myeloid Leukemia in Real Life Condition (LAM-BDD)

Acute Myeloid Leukemia

France
Hospices Civils de Lyon

Completed

Effect of Age on Treatment Decision-Making in Elderly Patients With Acute Myeloid Leukemia

Acute Myeloid Leukemia

France
Hospices Civils de Lyon

Completed

Economic Analysis of Blood Product Transfusions According to the Treatment of Acute Myeloid Leukaemia in the Elderly

Acute Myeloid Leukemia

France
Hospices Civils de Lyon

Completed

Higher Percentage of CD34+ CD38- Cells Detected by Multiparameter Flow Cytometry From Leukapheresis Products Predicts Unsustained Complete Remission in Acute Myeloid Leukemia

Acute Myeloid Leukemia

France
Institut Paoli-Calmettes

Unknown

Program of Evaluation and Geriatric Intervention on the Functional Status, Quality of the Life, and Survival (MLSP)

Acute Myeloid Leukemia

France
University Hospital, Bordeaux
General Electric; Fondation Plan Alzheimer

Unknown

Amyloïd Load in Elderly Population: Effect of Cognitive Reserve (EDUMA)

Plaque, Amyloid | Cognitive Deficits

France
Assistance Publique - Hôpitaux de Paris

Recruiting

Dynamics of Resistance Emergence to Azacitidine-based Therapies in Acute Myeloid Leukemia (DREAM)

Acute Myeloid Leukemia

France
Assistance Publique - Hôpitaux de Paris

Recruiting

A Study Comparing Allogeneic Hematopoietic Cell Transplantation Versus Best Available Standard of Care Therapy in Elderly Patients With Acute Myeloid Leukemia (ALLO-BEST)

Acute Myeloid Leukemia

France
Groupe Hospitalier Paris Saint Joseph

Completed

Cerebral Infarction and White Substance in Angiopathy Cerebral Amyloid

Amyloid Angiopathy

France
Institut Paoli-Calmettes

Completed

Laromustine, Daunorubicin, and Cytarabine in Treating Patients With Acute Myeloid Leukemia

Leukemia

France
Pfizer

Completed

Safety and Efficacy Study of Fx-1006A in Patients With Familial Amyloidosis

Familial Amyloid Polyneuropathy

United Kingdom, Spain, United States, Argentina, Brazil, France, Germany, Portugal, Sweden
Neurimmune AG

Completed

First-in-Human Study of NI006 in Patients With Amyloid Transthyretin Cardiomyopathy

Amyloid Transthyretin Cardiomyopathy

Germany, France, Netherlands, Spain
Hospices Civils de Lyon

Completed

Treatment With Low-Dose Cytarabine in Elderly Patients (Age 70 Years or Older) With Acute Myeloid Leukemia: A Single Institution Experience.

Acute Myeloid Leukemia

France
University Hospital, Toulouse
French Innovative Leukemia Organisation

Completed

Rapamycin in Combination With Low-dose Aracytin in Elderly Acute Myeloid Leukemia Patients (LAM-RAPA)

Acute Myeloid Leukemia

France
Centre Hospitalier Universitaire de Nīmes

Withdrawn

Florbetaben as an Amyloid Plaque Marker in Elderly Patients With Focal or Disseminated Superficial Hemosiderosis (FBB ACC)

Alzheimer Disease | Amyloid Cerebral Angiopathy

France
University Hospital, Angers

Recruiting

Outcome of Patients With CBF and/or NPM1-mutated AML in First Molecular Relapse. (MOLAM)

Acute Myeloid Leukemia

France
Centre Hospitalier Universitaire de Besancon
Centre Hospitalier Universitaire Dijon; Etablissement Français du Sang

Completed

AML Cell Immunotherapy Using Chimeric Antigen Receptor T-cells (CAR-LAM)

Acute Myeloid Leukemia

France
University Hospital, Strasbourg, France

Unknown

NGS in AML Relapse (NGSAML)

Acute Myeloid Leukemia

France

3

Subscribe